Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 4 , Pages 400-406 , July 2009

Differences in shotgun protein expression profile between superficial bladder transitional cell carcinoma and normal urothelium

  • Hai Tao Niu, Ph.D.

      Affiliations

    • Department of Urology, The Affiliated Hospital of Medical College Qingdao University, Qingdao, China
    • ,
  • Yi Bing Zhang, Ph.D.

      Affiliations

    • Department of Pathology, North China Coal Medical College, Tangshan, China
    • ,
  • Hai Ping Jiang, Ph.D.

      Affiliations

    • Department of Urology, The Affiliated Hospital of Medical College Qingdao University, Qingdao, China
    • ,
  • Bo Cheng, Ph.D.

      Affiliations

    • Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China
    • ,
  • Guang Sun, Ph.D.

      Affiliations

    • Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China
    • ,
  • Yi Wang, Ph.D.

      Affiliations

    • Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China
    • ,
  • Ya Jun E, Ph.D.

      Affiliations

    • Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China
    • ,
  • De Quan Pang, Ph.D.

      Affiliations

    • Department of Pathology, North China Coal Medical College, Tangshan, China
    • ,
  • Ji Wu Chang, Ph.D.

      Affiliations

    • Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China
    • Corresponding Author InformationCorresponding author. Tel.: +86-022-28311009; fax: +86-022-28311009

Received 19 December 2007 ,Revised 14 July 2008 ,Accepted 14 July 2008.

References 

  1. Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1999. CA Cancer J Clin. 1999;49:8–31
  2. Koss LG. Bladder cancer from a perspective of 40 years. J Cell Biochem. 1992;16I(Suppl):23–29
  3. Bane BL, Rao JY, Hemstreet GP. Pathology and staging of bladder cancer. Semin Oncol. 1996;5:546–570
  4. Nseyo UO, Lamm DL. Therapy of superficial bladder cancer. Semin Oncol. 1996;5:598–604
  5. Washburn MP, Wolters D, Yates JR. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol. 2001;19:242–247
  6. Li D, Li JQ, Yang SG, et al. An integrated strategy for functional analysis in large-scale proteomic research by gene ontology. Prog Biochem Biophys. 2005;32:1026–1029
  7. UniProt Consortium. The universal protein resource (UniProt). Nucleic Acids Res. 2008;36:D190–D195
  8. Tong W, Harris S, Cao X, et al. Development of public toxicoinformatics software for microarray data management and analysis. Mutat Res. 2004;549:241–253
  9. Saito M, Kimoto M, Araki T, et al. Proteome analysis of gelatin-bound urinary proteins from patients with bladder cancers. Eur Urol. 2005;48:865–871
  10. Rubinstein N, Alvarez M, Zwirner NW, et al. Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection: A potential mechanism of tumor-immune privilege. Cancer Cell. 2004;5:241–251
  11. Sheng KH, Yao YC, Chuang SS, et al. Search for the tumor-related proteins of transition cell carcinoma in Taiwan by proteomic analysis. Proteomics. 2006;6:1058–1065
  12. Scales CD, Peterson B, Dahm P. Interpreting statistics in the urological literature. J Urol. 2006;176:1938–1945
  13. Elsamman E, Fukumori T, Ewis AA, et al. Differences in gene expression between noninvasive and invasive transitional cell carcinoma of the human bladder using complementary deoxyribonucleic acid microarray: Preliminary results. Urol Oncol. 2006;24:109–115
  14. Ewis AA, El-Samman E, Ali N, et al. Gene expression profile in squamous cell carcinoma of the urinary bladder using complementary deoxyribonucleic acid microarray. Urol Oncol. 2007;25:120–127
  15. Duffy MJ, McGowan PM, Gallagher WM. Cancer invasion and metastasis: Changing views. J Pathol. 2008;214:283–293
  16. Golubovskaya VM, Cance WG. Focal adhesion kinase and p53 signaling in cancer cells. Int Rev Cytol. 2007;263:103–153
  17. Adachi J, Kumar C, Zhang Y, et al. The human urinary proteome contains more than 1,500 proteins including a large proportion of membranes proteins. Genome Biol. 2006;7:186–202
  18. Jubb AM, Chalasani S, Frantz GD, et al. Achaete-scute like 2 (ascl2) is a target of Wnt signaling and is up-regulated in intestinal neoplasia. Oncogene. 2006;25:3445–3457
  19. Jiang R, Mircean C, Shmulevich I, et al. Pathway alterations during glioma progression revealed by reverse phase protein lysate arrays. Proteomics. 2006;6:2964–2971
  20. Plas DR, Thompson CB. Cell metabolism in the regulation of programmed cell death. Trends Endocrinol Metab. 2002;13:75–78
  21. Fantin VR, St-Pierre J, Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell. 2006;9:425–434
  22. Perry RP. Balanced production of ribosomal proteins. Gene. 2007;401:1–3
  23. Fukuda MN, Miyoshi M, Nadano D. The role of bystin in embryo implantation and in ribosomal biogenesis. Cell Mol Life Sci. 2008;65:92–99

☆ J.W. Chang was supported for this work by the Tianjin Municipal Science and Technology Commission Tackle Key Problems in Science Foundation grant (043114211), and the National Science Foundation of China (NSFC 30371601/C03031903).

PII: S1078-1439(08)00163-4

doi: 10.1016/j.urolonc.2008.07.007

Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 4 , Pages 400-406 , July 2009

Article Tools

* Image Usage & Resolution